Form 4: PACB Insider Sells Shares for Tax Withholding

James R. Gibson II, CFO of Pacific Biosciences of California, Inc., sold 88,185 shares to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• James R. Gibson II, Chief Financial Officer of Pacific Biosciences of California, Inc. (PACB), reported a transaction on April 1, 2026.
• The transaction involved the sale of 88,185 shares of common stock.
• These shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units.
• The weighted average sale price for these shares was $1.37, with individual sales ranging from $1.35 to $1.39 per share.
• Following this transaction, Mr. Gibson beneficially owns 1,245,663 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard procedure for covering tax obligations related to equity compensation and not an indicator of a change in the insider's investment thesis.

Negatives

• Insider selling can sometimes be perceived negatively by the market, although this sale was for tax withholding purposes.
• The sale of a significant number of shares (88,185) could be interpreted as a reduction in insider confidence, despite the stated reason.

Future Outlook

No specific future outlook or guidance was provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are common events, particularly following the vesting of equity awards. While not indicative of a change in management's view on the company's prospects, the volume of shares sold can sometimes attract market attention.

Stakeholder Impact

• Shareholders: The sale is for tax withholding, so it does not directly impact the company's cash or operations. However, a large number of shares being sold by an insider might be perceived negatively in the short term.
• Employees: This transaction relates to the compensation of a specific executive and does not directly impact other employees.
• Creditors: No direct impact on creditors as the transaction involves the sale of existing shares by an insider.

Key Dates

Keywords

PACB, Pacific Biosciences of California, Inc., Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CFO, James R. Gibson II